These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 2226221)
21. The role of newer antiarrhythmic drugs in the management of patients with ventricular arrhythmias. Cain ME Angiology; 1988 Jul; 39(7 Pt 2):668-83. PubMed ID: 3044200 [TBL] [Abstract][Full Text] [Related]
23. Clinical antiarrhythmic efficacy of mexiletine: a review. Kulbertus HE Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663 [TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol. Advani SV; Singh BN Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009 [TBL] [Abstract][Full Text] [Related]
25. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy. Duff HJ; Rahmberg M; Sheldon RS J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588 [TBL] [Abstract][Full Text] [Related]
26. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo. Costard-Jäckle A; Franz MR J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease. Tanabe T; Takahashi K; Yoshioka K; Goto Y Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233 [TBL] [Abstract][Full Text] [Related]
28. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)]. Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. Van Durme JP Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664 [TBL] [Abstract][Full Text] [Related]
37. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing. Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693 [TBL] [Abstract][Full Text] [Related]
38. Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine. Podrid PJ; Kowey PR; Frishman WH; Arnold RJ; Kaniecki DJ; Beck JR; Beshansky JR Am J Cardiol; 1991 Dec; 68(17):1662-7. PubMed ID: 1836102 [TBL] [Abstract][Full Text] [Related]
39. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias. Giardina EG; Wechsler ME J Am Coll Cardiol; 1990 Apr; 15(5):1138-45. PubMed ID: 2179362 [TBL] [Abstract][Full Text] [Related]